HI
EVH icon

Harbour Investments’s Evolent Health EVH Stock Holding History

Harbour Investments’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.79K Buy
2,540
+315
+14% +$999 ﹤0.01% 3525
2025
Q4 		$8.9K Sell
2,225
-438
-16% -$2.44K ﹤0.01% 2795
2025
Q3 		$22.5K Sell
2,663
-175
-6% -$1.7K ﹤0.01% 2273
2025
Q2 		$32K Sell
2,838
-1,490
-34% -$13.7K ﹤0.01% 2017
2025
Q1 		$41K Sell
4,328
-5,860
-58% -$59.2K ﹤0.01% 1856
2024
Q4 		$115K Sell
10,188
-3,188
-24% -$56K ﹤0.01% 1299
2024
Q3 		$378K Sell
13,376
-340
-2% -$8.76K 0.01% 765
2024
Q2 		$262K Sell
13,716
-175
-1% -$4.47K 0.01% 840
2024
Q1 		$455K Buy
13,891
+660
+5% +$21.1K 0.02% 627
2023
Q4 		$437K Buy
13,231
+145
+1% +$4.1K 0.02% 573
2023
Q3 		$356K Sell
13,086
-500
-4% -$13.9K 0.02% 593
2023
Q2 		$412K Sell
13,586
-175
-1% -$5.66K 0.02% 548
2023
Q1 		$447K Sell
13,761
-75
-0.5% -$2.37K 0.02% 504
2022
Q4 		$389K Sell
13,836
-820
-6% -$23.5K 0.02% 524
2022
Q3 		$450K Hold
14,656
– – 0.03% 442
2022
Q2 		$450K Buy
+14,656
New +$427K 0.03% 442
2021
Q4 		$393K Sell
14,186
-2,885
-17% -$82.8K 0.02% 488
2021
Q3 		$529K Sell
17,071
-21,176
-55% -$508K 0.02% 624
2021
Q2 		$808K Buy
38,247
+890
+2% +$17.8K 0.03% 510
2021
Q1 		$755K Buy
+37,357
New +$710K 0.03% 473

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harbour Investments's EVH Position: Q1 2026 in Review

Harbour Investments increased its Evolent Health (EVH) stake by 14% in Q1 2026, buying an estimated $999 and bringing the position to 2,540 shares worth $5.79K. The position accounts for ﹤0.01% of the portfolio, ranked #3525.

Harbour Investments first reported a position in EVH in Q1 2021 and has held it in 20 quarters since. The position peaked at $808K in Q2 2021. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Harbour Investments held 2,540 shares of Evolent Health worth $5.79K as of Q1 2026.
  • Harbour Investments bought 315 Evolent Health shares in Q1 2026, an estimated $999.
  • Evolent Health made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3525 holding.
  • Harbour Investments first reported a position in Evolent Health in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Evolent Health position peaked at $808K in Q2 2021.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.